🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/11/2002 | 20,29 | 20,44 | 18,71 | 19,65 | +1,74% | 8,49% | 351.698 |
| 15/11/2002 | 18,38 | 19,50 | 18,27 | 19,31 | +5,09% | 6,72% | 289.929 |
| 14/11/2002 | 19,09 | 19,43 | 18,34 | 18,38 | -6,48% | 5,69% | 347.530 |
| 13/11/2002 | 20,21 | 21,52 | 17,97 | 19,65 | -26,47% | 17,59% | 1.740.484 |
| 12/11/2002 | 25,75 | 27,32 | 25,75 | 26,72 | +3,48% | 6,10% | 144.404 |
| 11/11/2002 | 27,10 | 27,70 | 25,27 | 25,83 | -6,76% | 8,98% | 54.368 |
| 08/11/2002 | 27,92 | 28,07 | 26,80 | 27,70 | -0,94% | 4,56% | 92.440 |
| 07/11/2002 | 27,51 | 29,01 | 27,32 | 27,96 | +2,05% | 6,12% | 158.563 |
| 06/11/2002 | 26,76 | 27,85 | 26,43 | 27,40 | +2,95% | 5,31% | 89.073 |
| 05/11/2002 | 27,02 | 27,29 | 26,39 | 26,61 | -2,34% | 3,32% | 101.630 |
| 04/11/2002 | 26,24 | 27,25 | 26,20 | 27,25 | +4,30% | 3,99% | 243.282 |
| 01/11/2002 | 24,55 | 26,13 | 24,03 | 26,13 | +6,08% | 8,54% | 100.855 |
| 31/10/2002 | 24,14 | 25,23 | 23,84 | 24,63 | +2,17% | 5,74% | 169.784 |
| 30/10/2002 | 24,18 | 25,19 | 23,77 | 24,10 | +0,62% | 5,88% | 134.812 |
| 29/10/2002 | 24,67 | 24,97 | 23,96 | 23,96 | -1,69% | 4,10% | 72.349 |
| 28/10/2002 | 25,00 | 25,83 | 24,33 | 24,37 | -1,21% | 5,99% | 106.893 |
| 25/10/2002 | 24,33 | 25,08 | 23,92 | 24,67 | +3,13% | 4,77% | 57.842 |
| 24/10/2002 | 25,45 | 26,95 | 23,92 | 23,92 | -6,85% | 11,91% | 94.283 |
| 23/10/2002 | 26,58 | 26,65 | 24,52 | 25,68 | -2,00% | 8,03% | 86.589 |
| 22/10/2002 | 26,80 | 26,80 | 25,30 | 26,20 | -1,96% | 5,59% | 126.210 |
| 21/10/2002 | 27,59 | 27,62 | 26,43 | 26,72 | -2,06% | 4,34% | 107.267 |
| 18/10/2002 | 27,70 | 27,70 | 25,83 | 27,29 | +1,25% | 6,76% | 101.096 |
| 17/10/2002 | 25,94 | 27,02 | 25,94 | 26,95 | +4,65% | 4,18% | 93.482 |
| 16/10/2002 | 25,98 | 26,65 | 24,93 | 25,75 | -1,57% | 6,63% | 57.120 |
| 15/10/2002 | 26,99 | 28,00 | 26,16 | 26,16 | -2,24% | 6,80% | 171.922 |
| 14/10/2002 | 25,15 | 27,10 | 24,89 | 26,76 | +5,93% | 8,78% | 69.490 |
| 11/10/2002 | 26,01 | 26,35 | 24,70 | 25,27 | -2,74% | 6,33% | 71.494 |
| 10/10/2002 | 23,62 | 26,58 | 23,39 | 25,98 | +10,33% | 13,47% | 82.180 |
| 09/10/2002 | 26,01 | 26,39 | 23,43 | 23,54 | -10,14% | 11,37% | 86.829 |
| 08/10/2002 | 24,37 | 26,20 | 23,99 | 26,20 | +9,38% | 9,06% | 72.990 |